Amneal Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AMRX Nasdaq 2834 www.amneal.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amneal Pharmaceuticals, Inc.

Amneal Reports First Quarter 2026 Financial Results - May 7th, 2026 2:01 pm
Amneal Pharmaceuticals Kashiv Deal Puts Biosimilar Growth And Valuation In Focus - May 5th, 2026 8:15 pm
Do Options Traders Know Something About Amneal Stock We Don't? - May 5th, 2026 10:18 am
How The Amneal Pharmaceuticals (AMRX) Story Is Shifting Around The New US$17 Price Target - May 5th, 2026 6:14 am
1 Value Stock to Target This Week and 2 Facing Challenges - May 4th, 2026 4:52 pm
UBS Initiates Coverage of Amneal Pharmaceuticals (AMRX) With a Bullish Outlook - May 1st, 2026 2:00 am
Is Amneal (AMRX) a Solid Growth Stock? 3 Reasons to Think "Yes" - Apr 29th, 2026 10:45 am
Wall Street Analysts See a 34.77% Upside in Amneal (AMRX): Can the Stock Really Move This High? - Apr 29th, 2026 7:55 am
Are Investors Undervaluing Amneal Pharmaceuticals (AMRX) Right Now? - Apr 29th, 2026 7:40 am
Are Medical Stocks Lagging Alignment Healthcare (ALHC) This Year? - Apr 29th, 2026 7:40 am
Assessing Amneal Pharmaceuticals (AMRX) Valuation After Strong Multi Year Returns And Recent Share Price Cooldown - Apr 25th, 2026 3:04 pm
Amneal Pharmaceuticals to Buy Kashiv BioSciences, Touts Strong Preliminary Q1 Results and Biosimilar Push - Apr 24th, 2026 8:35 am
Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Apr 23rd, 2026 7:30 am
AMRX Announces Kashiv BioSciences Buyout, Solid Q1 Preliminary Results - Apr 23rd, 2026 7:28 am
Amneal Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary - Apr 22nd, 2026 6:30 am
Amneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass Estimates - Apr 22nd, 2026 5:20 am
Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader - Apr 22nd, 2026 4:17 am
Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance - Apr 22nd, 2026 4:00 am
Amneal’s Parkinson’s And Respiratory Moves Shift Focus To Complex Therapies - Apr 21st, 2026 5:07 am
How The Amneal Pharmaceuticals (AMRX) Story Is Evolving Around 2026 Guidance And US$17 Targets - Apr 21st, 2026 2:06 am